Novo Nordisk A/S’s older weight-loss drug, Saxenda, helped children lose weight in a study, opening up the possibility of ...
A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with ...
Danish pharma giant Novo Nordisk has reported promising data on its new weight loss pill, which has been shown to lower body ...
Severe obesity is already a significant problem for many children, especially since obese children often become obese adults. Could the now popular weight-loss injection drugs be a solution for those ...
A recent study from KFF documents their meteoric rise: one in eight adults say they’ve taken a GLP-1 agonist, rising to one ...
The maker of a weight loss drug has asked regulators to allow them to expand the use of the medication down to the age of six. It comes as Liraglutide, a drug approved to treat obesity in adults and ...
Discover what the supplement Lemme GLP-1 Daily does and whether its ingredients are really effective for weight and blood ...
Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.
Clinical trials of a new, once-a-week insulin have shown that it controls blood sugar as well as daily injections of an ...
The New York Times: Deep Links Between Alcohol And Cancer Are Described In New Report Adults under age 50 have been developing breast cancer and colorectal cancer at increasingly higher rates ...
There are currently no pharmaceutical treatments approved for general obesity in under-12s — as opposed to that found with some rare genetic disorders — said Claudia Fox, a professor from University ...